Ping An Ventures logo

Ping An Ventures

Asia, Shandong, China, Pudong

Description

Ping An Ventures, also known as Ping An Innovation Investment Fund, operates as the corporate venture capital arm of Ping An Insurance (Group) Company of China, Ltd., one of the world's largest financial services conglomerates. Based in Pudong, China, this venture arm plays a crucial role in Ping An's broader strategy to foster innovation and identify emerging technologies that can complement or disrupt traditional financial and healthcare sectors. Its mandate extends beyond pure financial returns, actively seeking synergies with Ping An's extensive ecosystem, which spans insurance, banking, asset management, and healthcare services.

The firm primarily focuses its investments on startups within strategic emerging sectors. These include FinTech, Artificial Intelligence, Big Data, Healthcare, Smart City solutions, Automotive, Real Estate, and Agriculture. Ping An Ventures typically engages with companies across early to growth stages, ranging from Series A to Series C rounds. This broad stage focus allows them to support promising ventures from their initial commercialization phases through significant scaling, often leveraging Ping An's vast customer base and operational expertise to accelerate portfolio company growth.

Ping An Ventures has established itself as a significant player in the Chinese venture capital landscape. As of 2020, the Ping An Innovation Investment Fund had invested over RMB 20 billion, equivalent to approximately $3 billion USD, across more than 100 portfolio companies. This substantial capital deployment highlights their commitment to fostering innovation. While specific first check sizes can vary depending on the stage and sector, the fund typically participates in rounds with initial investments ranging from approximately $5 million to $50 million, often co-investing with other leading venture capital firms. Their strategic backing provides portfolio companies with not only capital but also access to Ping An's vast resources and market reach.

Investor Profile

Ping An Ventures has backed more than 20 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 10% of its total and boasts 20 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, China.
  • Strong thematic focus on Health Care, Biotechnology, Medical.
  • Typical check size: $5M – $50M.

Stage Focus

  • Series A (40%)
  • Series B (25%)
  • Series Unknown (10%)
  • Private Equity (10%)
  • Series D (10%)
  • Series C (5%)

Country Focus

  • United States (55%)
  • China (40%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Genetics
  • Therapeutics
  • E-commerce
  • Health Diagnostics
  • Manufacturing
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ping An Ventures frequently co-invest with?

AstraZeneca
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 2
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 2
Gilead Sciences
North America, California, United States, Foster City
Co-Investments: 2
Parker Institute for Cancer Immunotherapy
North America, California, United States, San Francisco
Co-Investments: 2
Novartis
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Virtus Inspire Ventures
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 2
Be The Match BioTherapies
North America, Minnesota, United States, Minneapolis
Co-Investments: 2
University of Pennsylvania
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 3
Trustbridge Partners
North America, Massachusetts, United States, Boston
Co-Investments: 3

Which angels does Ping An Ventures often collaborate with?

Patrick Cheung
Asia, Hong Kong
Shared Deals: 1
LL
North America, California, United States
Shared Deals: 1

What are some of recent deals done by Ping An Ventures?

Xiaoqule

Hangzhou, Zhejiang, China

Xiaoqule is a Chinese community-focused e-commerce platform.

E-CommerceRetailSocial Entrepreneurship
Series ANov 20, 2018
Amount Raised: $108,000,000
Global Scanner

Hangzhou, Zhejiang, China

Global Scanner is a social e-commerce platform targeting the middle-class in China.

E-Commerce
Series ANov 19, 2018
Amount Raised: $108,000,000
NextCure

Beltsville, Maryland, United States

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

BiopharmaBiotechnologyHealth CareOncology
Series BNov 13, 2018
Amount Raised: $93,000,000
Tmunity Therapeutics

Philadelphia, Pennsylvania, United States

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells.

BiotechnologyGeneticsHealth CareManufacturingTherapeutics
Series AApr 19, 2018
Amount Raised: $35,000,000
Hua Medicine

Shanghai, Shanghai, China

Hua Medicine is a clinical-stage, innovative drug development company in China.

BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
Series DMar 27, 2018
Amount Raised: $117,400,000
Rani Therapeutics

San Jose, California, United States

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

BiotechnologyPharmaceuticalTherapeutics
Series UnknownFeb 7, 2018
Amount Raised: $53,000,000
Tmunity Therapeutics

Philadelphia, Pennsylvania, United States

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells.

BiotechnologyGeneticsHealth CareManufacturingTherapeutics
Series AJan 23, 2018
Amount Raised: $100,000,000
KBP Biosciences

Princeton, New Jersey, United States

A multinational clinical stage biotechnology company.

BiotechnologyHealth CarePharmaceutical
Series AJan 5, 2018
Amount Raised: $76,000,000
Rogrand

Beijing, Beijing, China

Rogrand is a Chinese pharmaceutical industry chain service platform.

E-CommercePharmaceutical
Series CDec 21, 2017
Fabric Genomics (formerly Omicia)

Oakland, California, United States

Global healthcare platform for genomics-driven precision medicine. Fabric' proven AI algorithms power genomic insights.

Artificial Intelligence (AI)BioinformaticsBiotechnologyGeneticsHealth CarePrecision Medicine
Series BJun 8, 2016
Amount Raised: $23,000,000